Roflumilast Tablet
Product Images NDC 72205-201

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 72205-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Roflumilast-250mcg-10s-blister-foil-label (Roflumilast 250mcg 10s Blister Foil Label)

Blister card packaging label for Roflumilast Tablet 250 mcg by Novadoz Pharmaceuticals LLC. The label shows multiple tablets with each panel containing the product name, strength, manufacturer details, barcode, NDC 72205-201-11, and placeholders for lot number and expiration date. The tablets are indicated as prescription only, made in India, with peel and push instructions.*

FDA Label Image

Roflumilast-250mcg-14s-blister-foil-label (Roflumilast 250mcg 14s Blister Foil Label)

Roflumilast 250 mcg oral tablets blister pack from Novadoz Pharmaceuticals LLC, arranged with each tablet labeled by day of the week (Monday through Sunday). The pack shows daily dosing compartments with instructions to peel and push for access, including lot and expiration placeholders, indicating a 14-day supply.*

FDA Label Image

Roflumilast-250mcg-20s-blister-carton-label (Roflumilast 250mcg 20s Blister Carton Label)

Packaging label for Roflumilast Tablets 250 mcg, oral tablets supplied in a carton containing 20 tablets (2 x 10 unit-dose). The label shows the proprietary name Roflumilast, strength 250 mcg, and manufacturer Novadoz Pharmaceuticals LLC. It includes storage instructions, dosage information, and the National Drug Code (NDC) 72205-201-24. Manufactured by MSN Laboratories Private Limited in India.*

FDA Label Image

Roflumilast-250mcg-28s-blister-carton-label (Roflumilast 250mcg 28s Blister Carton Label)

Roflumilast Tablets 250 mcg oral tablets carton label. The package contains 28 tablets and is distributed by Novadoz Pharmaceuticals LLC. The label includes dosage strength of 250 mcg and displays the NDC 72205-201-32. Manufacturer information lists MSN Laboratories Private Limited, India.*

FDA Label Image

Roflumilast-500mcg-10s-blister-foil-label (Roflumilast 500mcg 10s Blister Foil Label)

Roflumilast Tablet 500 mcg label from Novadoz Pharmaceuticals LLC, made in India. The label includes the NDC 72205-200-11, batch/lot and expiration date placeholders, barcode, and instructions to peel and push for opening. Issued date is 08/2022. The label is repeated multiple times on the sheet for individual tablet packaging.*

FDA Label Image

Roflumilast-500mcg-30s-cntr-label (Roflumilast 500mcg 30s Cntr Label)

A drug information label for Roflumilast Tablets 500 mcg. It includes dosage instructions for adults, storage conditions, and warnings to keep out of reach of children. Manufacturer is MSN Laboratories Private Limited, India. Distributed by Novadoz Pharmaceuticals LLC, New Jersey, with a contact phone number. The label also includes an NDC number, barcode, and a note to dispense the accompanying medication guide to patients.*

FDA Label Image

Roflumilast-500mcg-90s-cntr-label (Roflumilast 500mcg 90s Cntr Label)

Roflumilast 500 mcg tablets packaging label showing the product name, strength, and quantity of 90 tablets. The label includes storage instructions, manufacturer MSN Laboratories Private Limited in India, and distributor Novadoz Pharmaceuticals LLC in Piscataway, NJ. It also shows NDC 72205-200-90 and a barcode.*

FDA Label Image

Roflumilast-500mcg-blister-carton-label (Roflumilast 500mcg Blister Carton Label)

Packaging label for Roflumilast Tablets 500 mcg, an oral prescription drug. The box contains 100 tablets packaged as 10 blister cards of 10 tablets each. Labeler is Novadoz Pharmaceuticals LLC, with manufacturing by MSN Laboratories Private Limited, India. The label includes storage instructions and a reminder to dispense the accompanying Medication Guide.*

FDA Label Image

Roflumilast-fig1 (Roflumilast Fig1)

A chart depicting fold changes in Cmax and AUC of Roflumilast and its metabolite Roflumilast N-oxide relative to reference, across various interacting drugs. The graph includes recommendations ranging from 'Use With Caution' to 'No Dose Adjustment' or 'Not Recommended' for each interacting drug listed.*

FDA Label Image

Roflumilast-structure (Roflumilast Structure)

Chemical structure of roflumilast, an active ingredient in oral tablet form used in prescription medications.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.